Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) Sees Large Drop in Short Interest

Orion OYJ Unsponsored ADR (OTCMKTS:ORINY) was the target of a significant drop in short interest in May. As of May 15th, there was short interest totaling 123 shares, a drop of 64.6% from the April 30th total of 347 shares. Currently, 0.0% of the shares of the stock are sold short. Based on an average daily volume of 21 shares, the days-to-cover ratio is currently 5.9 days.

Orion OYJ Stock Performance

Orion OYJ stock remained flat at $37.99 during mid-day trading on Friday. 19 shares of the company’s stock traded hands, compared to its average volume of 17. The company has a current ratio of 1.77, a quick ratio of 1.58 and a debt-to-equity ratio of 0.10. Orion OYJ has a twelve month low of $25.95 and a twelve month high of $42.75. The firm has a market capitalization of $10.72 billion, a PE ratio of 17.43 and a beta of 0.09. The business’s 50 day moving average price is $38.23 and its two-hundred day moving average price is $37.70.

Orion OYJ (OTCMKTS:ORINY) last posted its quarterly earnings data on Thursday, April 23rd. The company reported $0.37 earnings per share for the quarter. Orion OYJ had a net margin of 27.14% and a return on equity of 49.17%. The firm had revenue of $488.80 million for the quarter.

Orion OYJ Company Profile

Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.

Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.